Literature DB >> 11163107

Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells.

J W Park1, Y J Choi, M A Jang, Y S Lee, D Y Jun, S I Suh, W K Baek, M H Suh, I N Jin, T K Kwon.   

Abstract

Resveratrol, a natural product derived from grapes, has been shown to prevent carcinogenesis in murine models. We report here that resveratrol induces antiproliferation and arrests the S phase in human histiocytic lymphoma U937 cells. Resveratrol induces arrest in the S phase at low concentrations (30-60 microM), but high concentrations do not induce S phase accumulation in U937 cells. Removal of resveratrol from the culture medium stimulates U937 cells to reenter the cell cycle synchronously, as judged by the expression patterns of cyclin E, A and by fluorescent activated cell sorting analysis. These data demonstrate that resveratrol causes S phase arrest and reversible cell cycle arrest. Thus, resveratrol provides an important new cell cycle blocker as well as a cancer chemopreventive agent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163107     DOI: 10.1016/s0304-3835(00)00658-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

1.  High salt culture conditions suppress proliferation of rat C6 glioma cell by arresting cell-cycle progression at S-phase.

Authors:  Hideki Arimochi; Kyoji Morita
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells.

Authors:  Wei Zhang; Zhou Fei; Hai-Ning Zhen; Jian-Ning Zhang; Xiang Zhang
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

Review 3.  The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.

Authors:  Mary Ndiaye; Carol Philippe; Hasan Mukhtar; Nihal Ahmad
Journal:  Arch Biochem Biophys       Date:  2011-01-04       Impact factor: 4.013

Review 4.  Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells.

Authors:  Mary Jo Atten; Ernesto Godoy-Romero; Bashar M Attar; Thomas Milson; Matthew Zopel; Oksana Holian
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

Review 5.  Potential roles of longan flower and seed extracts for anti-cancer.

Authors:  Chih-Cheng Lin; Yuan-Chiang Chung; Chih-Ping Hsu
Journal:  World J Exp Med       Date:  2012-08-20

6.  Resveratrol inhibits cell growth by inducing cell cycle arrest in activated hepatic stellate cells.

Authors:  Izabel C Souza; Leo Anderson M Martins; Barbara P Coelho; Ivana Grivicich; Regina M Guaragna; Carmem Gottfried; Radovan Borojevic; Fátima Costa Rodrigues Guma
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

7.  Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer.

Authors:  Liang Yu; Zhong-Jie Sun; Sheng-Li Wu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol.

Authors:  Ashley C Huderson; Jeremy N Myers; Mohammad S Niaz; Mary K Washington; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2012-08-11       Impact factor: 6.048

9.  Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention.

Authors:  Christopher Hope; Kestutis Planutis; Marina Planutiene; Mary P Moyer; Karanjodh S Johal; Jaesung Woo; Calista Santoso; Joseph A Hanson; Randall F Holcombe
Journal:  Mol Nutr Food Res       Date:  2008-06       Impact factor: 5.914

10.  Synthesis, crystal structure, cytotoxicity and action mechanism of a Rh(iii) complex with 8-hydroxy-2-methylquinoline as a ligand.

Authors:  Yun-Liang Zhang; Qi-Pin Qin; Qian-Qian Cao; Hong-Hua Han; Zhu-Ling Liu; Yan-Cheng Liu; Hong Liang; Zhen-Feng Chen
Journal:  Medchemcomm       Date:  2016-10-25       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.